Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.81 0.66 −1.39%
Market cap
$111.8B
P/E
23.2×
Fwd P/E
—
Dividend yield
5.18%
F-score
7/9
Altman Z
2.50
Beneish M
−2.63
Dividend safety
54/100

Sanofi (SNY) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Sanofi (SNY) trades at a EV/FCF of 7.5×. Over the past ten years it has ranged from 4.7× (April 2024) to 15.9× (April 2015); the current reading is higher than 42% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 7.0× 10.93%
FY2024 6.3× 22.75%
FY2023 5.2× 2.87%
FY2022 5.0× (33.32%)
FY2021 7.5× (14.59%)
FY2020 8.8× 4.87%
FY2019 8.4× 22.61%
FY2018 6.8× 2.36%
FY2017 6.7× (18.81%)
FY2016 8.2× (16.27%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 6.7× (18.32%)
Jun 2026 8.2× 17.23%
Mar 2026 7.0× 0.17%
Dec 2025 7.0× (51.41%)
39 more quarters

Against its own ten years

Low 4.7× High 15.9×
Ten-year median 8.0×
Current reading's percentile 46

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on SNY